| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Istituto di Neurologia Università Cattolica del Sacro Cuore (Drs. Moro, Romito, Tonali, and Albanese), Rome, Italy; the Istituto di Neurochirurgia (Drs. Scerrati and Roselli), Università Cattolica del Sacro Cuore, Rome, Italy; and Casa Sollievo della Sofferenza (Dr. Tonali), San Giovanni Rotondo, Italy.
Address correspondence and reprint requests to Dr. Alberto Albanese, Istituto di Neurologia, Università Cattolica, Largo A. Gemelli 8, I-00168 Roma, Italy; e-mail: alberto.albanese{at}rm.unicatt.it
OBJECTIVE: To reduce antiparkinsonian medication in parkinsonian patients with bilateral high frequency subthalamic nucleus (STN) stimulation.
BACKGROUND: Parkinsonian syndromes are characterized by hyperactivity of the STN. Preliminary data indicate that functional inactivation of the STN may reduce the requirement for dopaminergic therapy in PD.
METHODS: Bilateral quadripolar leads were implanted stereotactically in the STN of seven patients with advanced PD (mean age, 57.4 years; mean disease duration, 15.4 years). High-frequency stimulation was applied for 24 hours a day. Following implantation, antiparkinsonian medication was reduced to the minimum possible and stimulation was gradually increased. The patients were evaluated in the practically defined "off" and "on" conditions using the Unified Parkinson’s Disease Rating Scale (UPDRS) and the Schwab & England scale. The average follow-up was 16.3 ± 7.6 months. A battery of neuropsychological tests was applied before and 9 months after the implant.
RESULTS: Parkinsonian features improved in all patients—the greatest change seen in rigidity, then tremor, followed by bradykinesia. Compared with the presurgical condition, off-drug UPDRS motor scores improved by 41.9% on the last visit (p = 0.0002), UPDRS activities of daily living (ADL) scores improved by 52.2% (p = 0.0002), and the Schwab & England scale score improved by 213% (p = 0.0002). The levodopa-equivalent daily dose was reduced by 65%. Night sleep improved in all patients due to increased mobility at night, and in five patients insomnia was resolved. All patients gained weight after surgery and their appetite increased. The mean weight gain at the last follow-up was 13% compared with before surgery. During the last visit, the stimulation amplitude was 2.9 ± 0.5 V and the total energy delivered per patient averaged 2.7 ± 1.4 W x 10-6. The results of patient self-assessment scales indicated a marked improvement in five patients and a moderate improvement in the other two. The neuropsychological data showed no changes. Side effects were mild and tolerable. In all cases, a tradeoff between the optimal voltage and the severity of side effects made it possible to control parkinsonian signs effectively. The most marked side effects directly related to STN stimulation consisted of ballistic or choreic dyskinesias of the neck and the limbs elicited by contralateral STN stimulation above a given threshold voltage, which varied depending on the individual.
CONCLUSIONS: Parkinsonian signs can be controlled by bilateral high-frequency STN stimulation. The procedure is well tolerated. On-state dyskinesias were greatly reduced, probably due to the reduction of total antiparkinsonian medication. Bilateral high-frequency STN stimulation compensated for drug reduction and elicited dyskinesias, which differ from those observed following dopaminergic medication. ADL improved significantly, suggesting that some motor tasks performed during everyday chores, and that are not taken into account in the UPDRS motor score, also improved.
This article has been cited by other articles:
|
|
 |
|
  F Klostermann, F Ehlen, J Vesper, K Nubel, M Gross, F Marzinzik, G Curio, and T Sappok Effects of subthalamic deep brain stimulation on dysarthrophonia in Parkinson's disease J. Neurol. Neurosurg. Psychiatry, May 1, 2008; 79(5): 522 - 529. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. U. Ferraye, B. Debu, V. Fraix, J. Xie-Brustolin, S. Chabardes, P. Krack, A-L Benabid, and P. Pollak Effects of subthalamic nucleus stimulation and levodopa on freezing of gait in Parkinson disease Neurology, April 15, 2008; 70(16_Part_2): 1431 - 1437. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Montaurier, B. Morio, S. Bannier, P. Derost, P. Arnaud, M. Brandolini-Bunlon, C. Giraudet, Y. Boirie, and F. Durif Mechanisms of body weight gain in patients with Parkinson's disease after subthalamic stimulation Brain, July 1, 2007; 130(7): 1808 - 1818. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Stefani, A. M. Lozano, A. Peppe, P. Stanzione, S. Galati, D. Tropepi, M. Pierantozzi, L. Brusa, E. Scarnati, and P. Mazzone Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease Brain, June 1, 2007; 130(6): 1596 - 1607. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Castner, H. J. Chenery, D. A. Copland, T. J. Coyne, F. Sinclair, and P. A. Silburn Semantic and affective priming as a function of stimulation of the subthalamic nucleus in Parkinson's disease Brain, May 1, 2007; 130(5): 1395 - 1407. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. -P. Derost, L. Ouchchane, D. Morand, M. Ulla, P. -M. Llorca, M. Barget, B. Debilly, J. -J. Lemaire, and F. Durif Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population? Neurology, April 24, 2007; 68(17): 1345 - 1355. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Teagarden and G. V. Rebec Subthalamic and Striatal Neurons Concurrently Process Motor, Limbic, and Associative Information in Rats Performing an Operant Task J Neurophysiol, March 1, 2007; 97(3): 2042 - 2058. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M F Contarino, A Daniele, A H Sibilia, L M A Romito, A R Bentivoglio, G Gainotti, and A Albanese Cognitive outcome 5 years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson's disease J. Neurol. Neurosurg. Psychiatry, March 1, 2007; 78(3): 248 - 252. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Moro, Y.-Y. W. Poon, A. M. Lozano, J. A. Saint-Cyr, and A. E. Lang Subthalamic Nucleus Stimulation: Improvements in Outcome With Reprogramming Arch Neurol, September 1, 2006; 63(9): 1266 - 1272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Uitti, Y. Baba, N. R. Whaley, Z. K. Wszolek, and J. D. Putzke Parkinson disease: Handedness predicts asymmetry Neurology, June 14, 2005; 64(11): 1925 - 1930. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Capecci, R A Ricciuti, D Burini, V G Bombace, L Provinciali, M Iacoangeli, M Scerrati, and M G Ceravolo Functional improvement after subthalamic stimulation in Parkinson's disease: a non-equivalent controlled study with 12-24 month follow up J. Neurol. Neurosurg. Psychiatry, June 1, 2005; 76(6): 769 - 774. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V Fraix, P Pollak, E Moro, S Chabardes, J Xie, C Ardouin, and A L Benabid Subthalamic nucleus stimulation in tremor dominant parkinsonian patients with previous thalamic surgery J. Neurol. Neurosurg. Psychiatry, February 1, 2005; 76(2): 246 - 248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Funkiewiez, C Ardouin, E Caputo, P Krack, V Fraix, H Klinger, S Chabardes, K Foote, A-L Benabid, and P Pollak Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease J. Neurol. Neurosurg. Psychiatry, June 1, 2004; 75(6): 834 - 839. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Devos, E. Labyt, P. Derambure, J. L. Bourriez, F. Cassim, N. Reyns, S. Blond, J. D. Guieu, A. Destee, and L. Defebvre Subthalamic nucleus stimulation modulates motor cortex oscillatory activity in Parkinson's disease Brain, February 1, 2004; 127(2): 408 - 419. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A.J. Esselink, R. M.A. de Bie, R. J. de Haan, M. W.P.M. Lenders, P. C.G. Nijssen, M. J. Staal, H. M.M. Smeding, P. R. Schuurman, D. A. Bosch, and J. D. Speelman Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD: A randomized trial Neurology, January 27, 2004; 62(2): 201 - 207. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N K Patel, P Plaha, K O'Sullivan, R McCarter, P Heywood, and S S Gill MRI directed bilateral stimulation of the subthalamic nucleus in patients with Parkinson's disease J. Neurol. Neurosurg. Psychiatry, December 1, 2003; 74(12): 1631 - 1637. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-L. Houeto, M.-L. Welter, P.-B. Bejjani, S. T. du Montcel, A.-M. Bonnet, V. Mesnage, S. Navarro, B. Pidoux, D. Dormont, P. Cornu, et al. Subthalamic Stimulation in Parkinson Disease: Intraoperative Predictive Factors Arch Neurol, May 1, 2003; 60(5): 690 - 694. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Schneider, U. Habel, J. Volkmann, S. Regel, J. Kornischka, V. Sturm, and H.-J. Freund Deep Brain Stimulation of the Subthalamic Nucleus Enhances Emotional Processing in Parkinson Disease Arch Gen Psychiatry, March 1, 2003; 60(3): 296 - 302. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T R K Varma, S H Fox, P R Eldridge, P Littlechild, P Byrne, A Forster, A Marshall, H Cameron, K McIver, N Fletcher, et al. Deep brain stimulation of the subthalamic nucleus: effectiveness in advanced Parkinson's disease patients previously reliant on apomorphine J. Neurol. Neurosurg. Psychiatry, February 1, 2003; 74(2): 170 - 174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Daniele, A Albanese, M F Contarino, P Zinzi, A Barbier, F Gasparini, L M A Romito, A R Bentivoglio, and M Scerrati Cognitive and behavioural effects of chronic stimulation of the subthalamic nucleus in patients with Parkinson's disease J. Neurol. Neurosurg. Psychiatry, February 1, 2003; 74(2): 175 - 182. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.E. Lang, G. Kleiner-Fisman, J.A. Saint-Cyr, J. Miyasaki, A. Lozano, J.L. Houeto, V. Mesnage, M.L. Welter, L. Mallet, Y. Agid, et al. Subthalamic DBS replaces levodopa in Parkinson's disease: Two-year follow-up Neurology, January 14, 2003; 60(1): 154 - 155. [Full Text] [PDF]
|
|
|
|
|
|
P. Krystkowiak, J.-L. Blatt, J.-L. Bourriez, A. Duhamel, M. Perina, S. Blond, J.-D. Guieu, A. Destee, and L. Defebvre Effects of Subthalamic Nucleus Stimulation and Levodopa Treatment on Gait Abnormalities in Parkinson Disease Arch Neurol, January 1, 2003; 60(1): 80 - 84. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Moro, R. J. A. Esselink, A. L. Benabid, and P. Pollak Response to levodopa in parkinsonian patients with bilateral subthalamic nucleus stimulation Brain, November 1, 2002; 125(11): 2408 - 2417. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Kleiner-Fisman, J.A. Saint-Cyr, J. Miyasaki, A. Lozano, A.E. Lang, F.J. G. Vingerhoets, J.G. Villemure, and J. Ghika Subthalamic DBS replaces levodopa in Parkinson's disease Neurology, October 22, 2002; 59(8): 1293 - 1294. [Full Text] [PDF]
|
|
|
|
|
|
E. Moro, R. J.A. Esselink, J. Xie, M. Hommel, A. L. Benabid, and P. Pollak The impact on Parkinson's disease of electrical parameter settings in STN stimulation Neurology, September 10, 2002; 59(5): 706 - 713. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Cunic, L. Roshan, F. I. Khan, A. M. Lozano, A. E. Lang, and R. Chen Effects of subthalamic nucleus stimulation on motor cortex excitability in Parkinson's disease Neurology, June 11, 2002; 58(11): 1665 - 1672. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J L Houeto, V Mesnage, L Mallet, B Pillon, M Gargiulo, S T. du Moncel, A M Bonnet, B Pidoux, D Dormont, P Cornu, et al. Behavioural disorders, Parkinson's disease and subthalamic stimulation J. Neurol. Neurosurg. Psychiatry, June 1, 2002; 72(6): 701 - 707. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M.A. Romito, M. Scerrati, M. F. Contarino, A. R. Bentivoglio, P. Tonali, and A. Albanese Long-term follow up of subthalamic nucleus stimulation in Parkinson's disease Neurology, May 28, 2002; 58(10): 1546 - 1550. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B-P Bejjani, I Arnulf, J-L Houeto, D Milea, S Demeret, B Pidoux, P Damier, P Cornu, D Dormont, and Y Agid Concurrent excitatory and inhibitory effects of high frequency stimulation: an oculomotor study J. Neurol. Neurosurg. Psychiatry, April 1, 2002; 72(4): 517 - 522. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Welter, J. L. Houeto, S. Tezenas du Montcel, V. Mesnage, A. M. Bonnet, B. Pillon, I. Arnulf, B. Pidoux, D. Dormont, P. Cornu, et al. Clinical predictive factors of subthalamic stimulation in Parkinson's disease Brain, March 1, 2002; 125(3): 575 - 583. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. J.G. Vingerhoets, J.-G. Villemure, P. Temperli, C. Pollo, E. Pralong, and J. Ghika Subthalamic DBS replaces levodopa in Parkinson's disease: Two-year follow-up Neurology, February 12, 2002; 58(3): 396 - 401. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Baunez, M. Amalric, and T. W. Robbins Enhanced Food-Related Motivation after Bilateral Lesions of the Subthalamic Nucleus J. Neurosci., January 15, 2002; 22(2): 562 - 568. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. N. Eskandar, G. R. Cosgrove, and L. A. Shinobu Surgical Treatment of Parkinson Disease JAMA, December 26, 2001; 286(24): 3056 - 3059. [Full Text] [PDF]
|
|
|
|
|
|
J.G. Nutt, S.L. Rufener, J.H. Carter, V.C. Anderson, R. Pahwa, J.P. Hammerstad, and K.J. Burchiel Interactions between deep brain stimulation and levodopa in Parkinson's disease Neurology, November 27, 2001; 57(10): 1835 - 1842. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Rizzone, M Lanotte, B Bergamasco, A Tavella, E Torre, G Faccani, A Melcarne, and L Lopiano Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: effects of variation in stimulation parameters J. Neurol. Neurosurg. Psychiatry, August 1, 2001; 71(2): 215 - 219. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Volkmann, N. Allert, J. Voges, P. H. Weiss, H.-J. Freund, and V. Sturm Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced PD Neurology, February 27, 2001; 56(4): 548 - 551. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Lopiano, M. Rizzone, B. Bergamasco, A. Tavella, E. Torre, P. Perozzo, M.C. Valentini, and M. Lanotte Deep brain stimulation of the subthalamic nucleus: Clinical effectiveness and safety Neurology, February 27, 2001; 56(4): 552 - 554. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Lang Surgery for Parkinson Disease: A Critical Evaluation of the State of the Art Arch Neurol, August 1, 2000; 57(8): 1118 - 1125. [Full Text] [PDF]
|
|
|
|
|
|
J. L. Molinuevo, F. Valldeoriola, E. Tolosa, J. Rumia, J. Valls-Sole, H. Roldan, and E. Ferrer Levodopa Withdrawal After Bilateral Subthalamic Nucleus Stimulation in Advanced Parkinson Disease Arch Neurol, July 1, 2000; 57(7): 983 - 988. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Houeto, P. Damier, P. B. Bejjani, C. Staedler, A. M. Bonnet, I. Arnulf, B. Pidoux, D. Dormont, P. Cornu, and Y. Agid Subthalamic Stimulation in Parkinson Disease: A Multidisciplinary Approach Arch Neurol, April 1, 2000; 57(4): 461 - 465. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
